Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Read more breaking news


EFSA health claim opinion

Clasado ‘surprised and disappointed’ by latest EFSA prebiotic rejection; promises action

By Shane Starling+


Clasado prebiotic claims rebuffed again. Firm continues to fight
Clasado prebiotic claims rebuffed again. Firm continues to fight

UK prebiotic specialist Clasado will contest the latest rejection of its gut health prebiotic science by the European Food Safety Authority (EFSA).

The firm was “surprised and disappointed” by the latest scientific rebuff, which came after dialogue with the agency during stop-the-clock procedures in the assessment process.

The company will respond with, "a number of areas of concern regarding the EFSA assessment itself”, Clasado said.

PR Neil Hunter told us “eyebrows had been raised” and the company would respond in the 30-day period for comments afforded to applicants after EFSA’s Panel on Dietetic Products, Nutrition and Allergies (NDA)  hands down its verdicts.

Clasado believed it had a strong chance to win the EU’s forst prebiotic health claim due to the presence of a new, unpublished intervention trial involving more than 400 subjects across four European nations.

Too subjective?

But theNDA said the gut health assessment methods were too subjective.

“…a combined measure of efficacy which would indicate whether the intervention provided adequate relief of symptoms of gastro-intestinal discomfort, was not assessed, and that measures of individual gastro-intestinal symptoms through validated questionnaires may only be used as supportive evidence for the scientific substantiation of health claims on the reduction of gastro-intestinal discomfort,” the panel said.

Bimuno is Clasado’s trademarked transgalactooligosaccharide.

The opinion can be found here .

White kidney bean & weight loss

Also rejected by EFSA this week was a submission from InQpharm Europe in the UK linking white kidney bean (Phaseolus vulgaris L.) and weight loss. Four human intervention trials did not sway the NDA which concluded of the key study that while it showed a weight loss effect, it was, “at risk of bias.”

It added a supporting study, “suffered from methodological limitations and that no evidence was provided for a mechanism by which the standardised aqueous extract from white kidney bean could exert the claimed effect.”

That opinion is here .


Swedish firm DoubleBad was also rejected for a submission for a insulin response influencing formulation containing L-threonine, L-valine, L-leucine, L-isoleucine, L-lysine and chromium picolinate.

Double Bad said the blend could stimulate, “insulin release via the insulinogenic properties of the amino acids in the food”.

The NDA said, “the evidence provided by the applicant does not establish that a reduction in post-prandial glycaemic responses achieved by an increase in insulin secretion is a beneficial physiological effect for the target population in the context of this application.”

The opinion is here .

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars